-
Siltuximab (INN), sold
under the
brand name
Sylvant, is used for the
treatment of
people with
multicentric Castleman's disease. It is a
chimeric (made...
-
entrepreneur and
business executive. He is the co-founder and
director of
Sylvant Advisors, in the
field of
education management; CEO and MD of Head Held...
-
SPJIMR alumni include:
Business Madan Padaki, co-founder and
director of
Sylvant Advisors Girish Wagh, head,
commercial vehicle business unit Tata Motors...
- (INN)
suxemerid (INN)
suxethonium chloride (INN)
suxibuzone (INN)
Syfovre Sylvant Symadine Symbyax symclosene (INN)
symetine (INN)
Symmetrel Synacort Synagis...
- (brand)
Rembrandt toothpaste Rolaids RWJ-51204
Savlon Sinutab Splenda Sylvant Telaprevir Tipifarnib Buildings Johnson and
Johnson Plaza Related 2010...
- an
antibody directed against the IL6-receptor. The second,
siltuximab (
Sylvant), is
directed against IL-6 itself.
Siltuximab is
approved for treatment...
-
systemic lupus erythematosus (SLE), dermatomyositis,
polymyositis Siltuximab Sylvant mab
chimeric IL-6 Y
cancer Simtuzumab mab
humanized LOXL2
fibrosis Siplizumab...
-
human IL17A
Plaque psoriasis Ankylosing spondylitis 125504 Link
siltuximab Sylvant Janssen Biotech 4/23/2014
intravenous chimeric IL6
Multicentric Castleman's...
- 677–84. doi:10.1097/SLA.0b013e318249dcdc. PMID 22367441. S2CID 7553851. "
SYLVANT™ (siltuximab)
Receives FDA
Approval to
Treat Multicentric Castleman's Disease...
- Pays de Montbéliard Agglomération
Government • Mayor (2020–2026)
Alain Sylvant Area 1 11.02 km2 (4.25 sq mi) Po****tion (2021) 491 • Density 45/km2...
